We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
(+7.8%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$37.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$29.3M |
| 3 |
Biogen
BIIB
|
+$27.4M |
| 4 |
Home Depot
HD
|
+$22.7M |
| 5 |
Cisco
CSCO
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$23.6M |
| 2 |
TJX Companies
TJX
|
+$19.3M |
| 3 |
FedEx
FDX
|
+$16.4M |
| 4 |
Intuit
INTU
|
+$14.7M |
| 5 |
Corning
GLW
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.18% |
| 2 | Technology | 17.19% |
| 3 | Financials | 12.85% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Crown Castle
CCI
$32.7B
| $3.17M | 0.05% |
29,435
-475
| -2% | -$49.3K |
|
377
Bank of Montreal
BMO
$125B
| $3.16M | 0.05% |
40,950
-4,945
| -11% | -$381K |
|
|
ARQL
378
DELISTED
Arqule Inc
ARQL
| $3.13M | 0.05% |
565,000
+355,000
| +169% | +$1.36M |
|
|
COL
379
DELISTED
Rockwell Collins
COL
| $3.07M | 0.05% |
22,805
+2,629
| +13% | +$356K |
|
380
Kraft Heinz
KHC
$30.4B
| $3.06M | 0.05% |
48,704
+1,564
| +3% | +$92.8K |
|
|
KTWO
381
DELISTED
K2M Group Holdings, Inc
KTWO
| $3.04M | 0.05% |
135,000
+20,000
| +17% | +$422K |
|
382
State Street
STT
$50.9B
| $3.03M | 0.05% |
32,558
-16,461
| -34% | -$1.63M |
|
|
MYOK
383
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $3.03M | 0.05% |
61,000
| – | – |
|
384
Campbell Soup
CPB
$6.51B
| $3.02M | 0.05% |
74,410
+15,714
| +27% | +$612K |
|
385
Enbridge
ENB
$124B
| $3.01M | 0.05% |
84,362
-8,737
| -9% | -$277K |
|
|
NATI
386
DELISTED
National Instruments Corp
NATI
| $3.01M | 0.05% |
71,695
+6,572
| +10% | +$291K |
|
387
Public Storage
PSA
$60.2B
| $3M | 0.05% |
13,243
-262
| -2% | -$54.6K |
|
388
T. Rowe Price
TROW
$25B
| $2.98M | 0.05% |
25,681
-70,811
| -73% | -$8.23M |
|
389
Manulife Financial
MFC
$72.6B
| $2.95M | 0.05% |
164,173
-9,673
| -6% | -$182K |
|
390
Carnival Corporation Ltd
CCL
$36.1B
| $2.93M | 0.05% |
51,103
+21,424
| +72% | +$1.36M |
|
391
Revvity
RVTY
$12.3B
| $2.93M | 0.05% |
40,000
-670
| -2% | -$50.3K |
|
|
GAP
392
The Gap Inc
GAP
$6.84B
| $2.92M | 0.05% |
90,075
-113,244
| -56% | -$3.48M |
|
393
Raymond James Financial
RJF
$32.5B
| $2.91M | 0.05% |
48,780
-87,138
| -64% | -$5.41M |
|
394
Moody's
MCO
$81.7B
| $2.88M | 0.05% |
16,906
-7,862
| -32% | -$1.33M |
|
395
Church & Dwight Co
CHD
$23.1B
| $2.88M | 0.05% |
54,233
-129,444
| -70% | -$6.27M |
|
396
Canadian Natural Resources
CNQ
$96.9B
| $2.88M | 0.05% |
163,154
-57
| -0% | -$965 |
|
397
SBA Communications
SBAC
$18.4B
| $2.83M | 0.04% |
17,147
-167
| -1% | -$26.9K |
|
398
JD.com
JD
$40.8B
| $2.83M | 0.04% |
72,600
-11,010
| -13% | -$425K |
|
399
Baxter International
BAX
$11.6B
| $2.82M | 0.04% |
38,148
-2,171
| -5% | -$153K |
|
|
BPMC
400
DELISTED
Blueprint Medicines
BPMC
| $2.79M | 0.04% |
44,000
| – | – |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2018 Portfolio in Review
As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.
- Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
- Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
- Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
- Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
- Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
- Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
- Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.
Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.